Background: This study was conducted to evaluate the diagnostic validity of the 13 C-urea breath test ( 13 C-UBT) in the remnant stomach after partial gastrectomy for gastric cancer.
INTRODUCTION
Helicobacter pylori is known the primary cause leading to chronic atrophic gastritis and peptic ulcer disease. 1 This bacteria also associated with gastric cancers and mucosa-associated lymphoid tissue lymphoma. 2, 3 World Health Organization has reported H. pylori as a group 1 carcinogen, and the eradication of H. pylori infection reduces the risk of gastric cancer development, and prevents recurrences of these diseases. [4] [5] [6] For the treatment of gastric cancer, curative attempts to resect gastric cancer leave a gastric stump, creating the possibility of metachronous tumors arising from the remnant stomach. Thus, many post-surgical management strategies have been attempted to lessen the risk of gastric cancer recurrence, such as adjuvant chemotherapy, regular endoscopic surveillance, and H. pylori eradication. After surgical resection, gastric surgery places patients in a different condition from those with a previous normal stomach. Subtotal gastrectomy can decrease the gastric emptying time, 7, 8 and increased bile reflux cause the changes of the hydrophobic gastric mucosal barrier, 9 or enhanced blood flow in the remnant gastric body. 10 For these reasons, it is crucial to survive or to detect for H.
pylori in the remnant stomach, and the reported rates of H. pylori infection in the remnant stomach after distal gastrectomy fall within a broad range (19%-70%). [11] [12] [13] H. pylori infections can be diagnosed by a variety of invasive and non-invasive methods. 14 Endoscopic biopsy is the gold standard, but it is invasive and is prone to sampling error because H. pylori tends to be heterogeneously distributed in the stomach. 15 Serologic examinations are noninvasive and convenient, but do not accurately reflect infection status. 16 The urea breath test (UBT) using 13 C-labeled urea is a noninvasive test based on the potent urease activity of H. pylori in gastric mucosa and was developed to overcome the shortcomings of serologic testing. This test has been widely used because it has been reported to have a sensitivity and specificity greater than 90% for detecting H. pylori infection, and to be more convenient to use and safer for patients. 17, 18 For these reasons, the 13 C-UBT is now routinely used for diagnosis of H. pylori infection. However, information on the diagnostic efficacy of the 13 C-UBT for the detection of H. pylori in the remnant stomach after partial gastrectomy is limited. 12, [19] [20] [21] Furthermore, the diagnostic accuracy of this test is controversial for the reason that the changed gastric anatomy could affect the result of the 13 C-UBT. In this present study, we evaluated the diagnostic validity of the 13 C-UBT after H. pylori eradication by comparing 13 C-UBT result with that of endoscopic biopsy in the gastrectomized patients. Endoscopic surveillances were performed at least on two occasions during follow-up after 13 C-UBT without any further H. pylori treatment. The exclusion criteria applied were: (1) no follow up history of endoscopic surveillance after 13 C-UBT; (2) the administration of antibiotics or the consumption of bismuth salts within 4 weeks or the administration of a proton pump inhibitor (PPI) within 2 weeks prior to 13 C-UBT; (3) H. pylori eradication failure because of poor compliance; (4) a history of total gastrectomy; (5) H. pylori re-infection, where H. pylori status became positive after more 1 year after successful eradication. 26 The study protocol was approved by the Ethics Committee at Seoul National University Bundang Hospital (SNUBH B-1406). 3.
MATERIALS AND METHODS

Helicobacter pylori eradication
C-urea breath test
Before the 13 C-UBT, patients were instructed to stop taking medications (such as bismuth salts or antibiotics for 4 weeks and PPI for 2 weeks), and fasted for a minimum of 4 hours. After washing the oral cavity by gargling, a predose breath sample was obtained. Then, 100 mg tablet of 13 C-urea (UBiTkit TM , Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan) was administered free of citric acid. Breath samples were collected in the sitting position using special breath collection bags before 13 C-urea administration (baseline) and 20 minutes after administration. Collected breath samples were analyzed using an isotope-selective, nondispersive infrared spectrometer (UBiT-IR 300 Ⓡ , Otsuka Pharmaceutical Co. Ltd, Tokyo, Japan). Despite the lack of validation, a 13 C-UBT cut-off value 2.5‰ was used as recommended by the manufacturer, and thus, a delta 13 CO2 of ≥ 2.5‰ was considered positive for H. pylori infection.
Endoscopic surveillance for the detection of
Helicobacter pylori infection and histological evaluation To improve the H. pylori detection rate, three gastric biopsies were obtained from the antral side of the anastomotic site, lesser curvature and greater curvature of body in the remnant stomach. C-UBT value four-point scale (i.e., 0 = none, 1 = slight, 2 = moderate, and 3 = marked). 30 
Mucosa urease test
Two biopsy specimens, one from the lesser curvature of the anastomosis site and lesser curvature of body, were used for the rapid urease test (CLOtest, Delta West). Anastomosis site and body biopsy specimens in the remnant stomach were evaluated separately, and all urease tests were monitored for color change for up to 24 hours.
Microbiological examination
Two specimens from the antrum and body were sent for microbiological culture in brain heart infusion plates containing 7% horse blood. These plates were placed in a glass tank in a 5% O2, 10% CO2, and 85% N2 atmosphere at 37 o C for 3-5 days. Anastomosis site and body biopsy specimens in the remnant stomach were evaluated separately. Organisms were identified as H. pylori by Gram staining, colony morphology, and positive oxidase, catalase, and urease reactions.
Statistical analysis
Sensitivity, specificity, false positive rate, false negative rate, positive predictive value, negative predictive value for the 13 C-UBT in the partial gastrectomy state were calculated. Statistical analysis was conducted using PASW Statistics ver. 18.0 (IBM Co., Armonk, NY, USA). The Student's t-test, Pearson's chi-square test, and Fisher's exact test were used, as appropriate, for the univariate analysis of factors affecting the accuracy of the 13 C-UBT, and a logistic regression model was used for the multivariate analysis. P-values of ＜ 0.05 were considered statistically significant.
RESULTS
Subject characteristics
Of the 161 patients with a 13 C-UBT result after partial gastrectomy state, forty seven patients (29.2%) had a 13 C-UBT result ≥ 2.5‰ and 114 patients (70.8%) had a value ＜ 2.5‰. Baseline patient characteristics are shown in Table 1 . There were 97 males (60.2%) and 64 females (39.8%) with a mean patient age of 58.6 (30-78) years. Indications for operations were early gastric cancer in 125 patients (77.6%) and advanced gastric cancer in 36 patients (22.4%). Analyzing method of gastrectomy, Billroth I, II anastomosis, Roux-en-Y anastomosis, wedge resection and proximal gastrectomy were carried out for reconstruction of the gastrointestinal tract in 106 (65.8%), 6 (3.8%), 29 (18.0%), 11 (6.8%) and 9 (5.6%) patients. 17 (10.6%) and 27 (16.8%) patients had diabetes mellitus and hypertension, respectively. Before the 13 C-UBT, 110 patients (68.3%) underwent the first-line eradication therapy, 41 patients (25.5%) underwent second-line eradication therapy, and 10 patients (6.2%) underwent third-line eradication therapy (Table 1) .
2. The diagnostic accuracy of 13 C-urea breath test in the gastrectomized patients A flowchart of the study is shown in Figure 1 . All 161 patients were evaluated for H. pylori status by histology and using the CLOtest. But H. pylori culture was performed in 8 patients during the endoscopic surveillance after the 13 C-UBT. The success rate of culture was 87.5%. 7 patients were proved H. pylori infection on the culture methods. When H. pylori statuses was analyzed based on biopsy-based methods, 25 patients (15.5%) had a positive result for H. pylori infection, and 136 patients (84.5%) were H. pylori negative (Fig. 1 ).
In patients with a negative CLOtest, and/or culture showed 21 patients (44.7%) were H. pylori positive and 26 patients (55.3%) were H. pylori negative (Fig. 1) .
When the diagnostic accuracy of the 13 C-UBT was calculated versus endoscopic biopsy results, its sensitivity, specificity, false positive rate, and false negative rate were 84.0%, 80.9%, 19.1%, and 16.0%, respectively. Its positive and negative predictive values were 44.7% and 96.5%, respectively (Table 2) . (Table 3) . Logistic regression analysis confirmed that multiple prior eradication therapies (odds ratio = 3.248, 95% confidence interval = 1.088-9.695, P = 0.035) was associated with the mismatching of 13 C-UBT and biopsy results after H. pylori eradication (Table 4) .
DISCUSSION
The results of the present study suggest that there was a poor diagnostic concordance between the 13 C-UBT and endoscopic biopsy-based results in the positive 13 C-UBT values (≥ 2.5‰) after H. pylori eradication in remnant stomach after partial gastrectomy for gastric cancer. Generally, the 13 C-UBT has been reported to be one of the most accurate diagnostic tools for assessing H. pylori status, 31, 32 and due to its speed, cost-effectiveness, and convenience, this test has been widely adopted in clinical practice. 33 After partial gastrectomy, the gastric anatomy is altered and the test urea might be expected to pass through the stomach faster, giving different reactant percentages in reaction time, or the 13 C-UBT results could be influenced by bile acid reflux. Several reports have shown that 13 C-UBT provides lower diagnostic accuracy when using histology as a reference in the remnant stomach after partial gastrectomy. [34] [35] [36] Previously,
Lotterer et al. 20 reported that the 13 C-UBT had shown a 100% sensitivity and 80% specificity in patients with partial stomach resection. In a Japanese study, the sensitivity, specificity, and accuracy of the 13 C-UBT were shown to be 96.3%, 100%, and 97.1% in the remnant stomach. 21 However, Schilling et al. 12 reported that the sensitivity of the 13 C-UBT was 52%, the specificity 93%. The positive predictive value was 81.25%, the negative predictive value 76.9% and the accuracy was 77.9%. In our study, the sensitivity, specificity, false positive rate, and false negative rate of the C-UBT occasionally has poor diagnostic ability as compared with endoscopic biopsy-based methods. 18 However, endoscopic biopsy-based methods are susceptible to sampling errors because of discontinuous H. pylori colonization of the stomach. 37 In our study, gastric biopsies were performed and the samples were obtained from the anastomosis site and the body of the remnant stomach for histological analysis (modified Giemsa staining), and a gastric sample was obtained from both anastomosis site and body for rapid urease testing. H. pylori culture was performed using samples from the gastric biopsies, that is, 2 samples from the anastomosis site and from the body. Furthermore, all patients received at least two or more follow-up endoscopic surveillances, which re-confirmed final H. pylori statuses. Thus, we believe the possibility of a gastric biopsy sampling error was slight. Considering a change of anatomical status of the stomach, postgastrectomy-induced hypochlorhydria often results in bacterial colonization of the remnant stomach. Urease-producing bacteria (Streptococcus, Staphylococcus, Gardnerella, Lactococcus, and Enterococcus) could cause false positive results. [38] [39] [40] [41] In a hypochlorhydric state of the remnant stomach, it accelerates the colonization and the overgrowth of non-H. pylori urease-positive bacteria. Furthermore, elevation of intragastric pH removes the neutralizing action of hydrochloric acid on local ammonia production by H. pylori urease, leading to the ultimate death of the bacterium as a result of overalkalization. 42 Previous study showed that the persistence of H. pylori in the residual stomach decreased from 68.8% to 36% as time elapsed after surgery went from less than 1 year to more than 3 years without any eradication. 19 According to a Taiwan study, spontaneous clearance of H. pylori develops in a certain number of patients who underwent distal gastrectomy. 43 In this study, they reported decreased prevalence of H. pylori colonization was found after partial gastrectomy without additional eradication therapy: 1-15 years, 29.5%; 16-30 years, 13.6%; and ＞ 31 years, 10%. Final spontaneous clearance rate of H. pylori after partial gastrectomy was 43%. For these backgrounds, the possibility of the spontaneous clearance of H. pylori (duration from 13 C-UBT to endoscopic biopsies: 6 month to 1 year) would be caused the mismatch results.
For another important factor, regarding the role of bile reflux on H. pylori colonization in the remnant stomach after partial gastrectomy, many conflict results were published. According to a study by Onoda et al., 44 the prevalence of H. pylori infection was lower in Billroth-II reconstruction patients with severe bile reflux and subsequent stomal gastritis, suggesting a spontaneous eradication of H. pylori by the reflux of bile contents. Thus, subtotal gastrectomy allows bile reflux; they therefore cause more severe gastritis with decreased H. pylori infection. Although we could not evaluate the degree of bile reflux in the patients who had received subtotal gastrectomy, the reflux of bile acid might influence on H. pylori survival after 13 C-UBT, and it might cause the mismatch result between the 13 C-UBT and endoscopic biopsy methods. However, a previous study reported that Roux-en-Y reconstruction after distal gastrectomy produces smaller amounts of bile reflux and as a result had a lower rate of H. pylori infection. 45 Nakagawara et al. 46 reported that bile refluxate facilitated the survival of H. pylori, speculating that H. pylori was perhaps inhibited by other bacteria in the gut. Pylorus-preserving gastrectomy for gastric cancer also resulted in significantly lower H. pylori prevalence after surgery. 43 Thus, the precise mechanism between bile acid reflux and H. pylori survival would be required to further investigation. Considering the accuracy of the 13 C-UBT, Sheu et al. 19 reported that the sensitivity and specificity of the UBT in the gastrectomy group were lower than those in the normal group. Applying a cut-off value as 2.5‰, the sensitivity and specificity were only 82.2% and 87.8%, respectively. They explained that such a poor UBT diagnostic efficacy in the gastrectomized patients can be attributed in part to the lower bacterial loads, inadequate coating of the stomach by urea, and disuse of test meal. Kubota et al. 21 established a standardized protocol and cut-off value for the 13 C-UBT in gastrectomized patients. Using receiver operating characteristic analysis, they selected 40 minutes and a cut-off of 2.0‰. As the delta over baseline (DOB) 13 CO2 of H. pylori non-infected patients mainly reflect urease activity in the mouth, surgery should have no effect and the cut-off should be set appreciably higher. 47 Graham et al. 48 originally reported that a test meal was required before urea ingestion to similarly extend the period of contact between urea and H. pylori. Most studies evaluating the need for citric acid in UBT showed higher delta values with citric acid when compared with other test meals or no test meals. [49] [50] [51] Citric acid is expected to increase delta values in infected patients and not change delta values in uninfected ones. Adding citric acid may, therefore, well increase the discriminative capacity of the test. 49 In previous our reports, 52 we also reported a high false positive results of the 13 C-UBT after eradication of H. pylori in the normal patients. In line with previous reports, no application of the citric acid test meal for the test would be cause such a high rate of false positive results in this study.
In the present study, we also sought to identify clinical factors that caused false positive However, this present study also has some limitations. First, we could not compare 13 C-UBT and endoscopic biopsy results at the same time. According to the Korean Health Insurance service, these two tests should not be performed simultaneously after H. pylori eradication. Therefore, in this study, we evaluated H. pylori status endoscopically at least 6 months after the 13 C-UBT. Thus, the high false positive results of the 13 C-UBT might be influenced by the altered stomach environment, such as, increasing pH, bile reflux acid, and unused of test meal. Second, this study is intrinsically limited by its retrospective design. In particular, 42.3% of patients who performed 13 C-UBT after receiving subtotal gastrectomy were enrolled, which introduce the possibility of sampling bias. Especially, the cases of the positive 13 C-UBT result were lesser than half of negative results of the 13 C-UBT. Third, the results of our study could be applied to post-H. pylori eradication status rather than initial diagnosis of H. pylori infection. Under the Korean National Medical Insurance system, it is difficult to obtain 13 C-UBT values before H. pylori eradication. Furthermore, a well-designed, randomized, controlled study is needed to confirm the diagnostic validity of the 
